Products for Research Use Only
RegisterLogin

Ocaratuzumab

CAT: 0804-HY-P99308-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99308-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Ocaratuzumab (AME 133v) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC) [1][2].
CAS Number
1169956-08-4
Product Name Alternative
AME 133v; LY 2469298; Humanized Anti-MS4A1 Recombinant Antibody
UNSPSC
12352203
Target
CD20
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ocaratuzumab.html
Purity
95.00
Solubility
H2O
Smiles
[Ocaratuzumab]
Molecular Weight
(145.38 kDa)
References & Citations
[1]Forero-Torres A, et, al. Results of a phase 1 study of AME-133v (LY2469298), an Fc-engineered humanized monoclonal anti-CD20 antibody, in FcγRIIIa-genotyped patients with previously treated follicular lymphoma. Clin Cancer Res. 2012 Mar 1;18 (5) :1395-403.|[2]Cheney CM, et, al. Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia. MAbs. 2014 May-Jun;6 (3) :749-55.
Shipping Conditions
Blue Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
abx831256-01Ocaratuzumab
GTR18337960-01Ocaratuzumab Antibody
E55B0319Ocaratuzumab (Reference antibody)
KDC90707Ocaratuzumab ELISA Kit
C00704-1mg*25Ocaratuzumab (Anti-CD20)
HY257126-01Research Grade Ocaratuzumab
592056Ocaratuzumab (MS4A1, CD20)
048162CD20 (ocaratuzumab) discontinued

Popular Products